Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
January meeting with FDA to lay out Expedited Access Pathway (EAP) to facilitate patients' access to breakthrough medical device.
It will soon be obvious to the world that the effective filtration of virus and tumor secreted exosomes by the Hemopurifier can assist in the cure and/or prevention of several diseases. Sepsis, HepC, Aids, Ebola,Chikungunya,Dengue fever and cancer for starters.
Diagnostic using blood sample does not remove Tau from the brain. Study indicates a strong correlation between Tau levels in the brain and tausome levels in the blood. CTE therapy will likely be a drug. Hopefully, CTE diagnosis will be tausome assay.
This study tells me that it will be nearly impossible to develop a anti-viral drug cocktails effective against a rapidly mutating virus like Ebola. In fact, the way I read it, the study says Zmapp actually promoted rapid mutations of Ebola virus. Looks like more evidence that the HP should be deployed as a broad spectrum therapeutic countermeasure against many deadly viruses.
Should be good. Company is now on solid financial footing. There should be an upward trend over the next few months, as AEMD becomes more and more attractive to early investors who have been watching DARPA program and clinical trials progress. Then there should be a nice bump up when uplisted to NASDAQ and major news on safety trials, procurements, etc. is released. There is also potential for significant news out of India.
Exthera's binding of bacteria and Cytomegalovirus using Heparin based anticoagulant binding materials, sounds like nice complements to the HP's capabilities in treating Sepsis. No worries.
Pray for the patient and pray for the HP.
Binding of bacteria and Cytomegalovirus using Heparin based anticoagulant binding materials - nice complements to the HP's capabilities. No worries.
Your wasting money on commissions bassque. Aethlon is tight with FDA and DoD and smart people know it.
The info about the affinity agent's availability was provided to me a long time ago.
JJ told me that the availability of the lectin affinity agent used in the HP is not an issue. I appreciate the concern.
I see a sudden drop of viral load on day 13... duh...
http://www.thelancet.com/cms/attachment/2022456692/2042373635/gr2_lrg.jpg
Are you seriously surprised that some MDs are skeptical of a medical device? They aren't called pill pushers for nothing.
exski - it stands to reason that removal of the viral load, whenever it occurred in relation to other factors, played a life saving role. This can be concluded by the simple fact that other patients receiving comparable treatments, without the boost from the Hemopurifier, have died. Correct me if I'm wrong and avoid medical terms that fail to impress me.
gary - which patient survived? The one who had HP treatment or those that died without it?
Maggie Fox - paid by big pharma for disinformation vs perceived threats?
Thanks for the Forbes video. Simply stated, my conclusion is that these people would rather let the people in Africa die than doing anything besides developing drugs and vaccines for possible future use." ...Sad if such people call the shots... Guess we can only hope that there is some room for the Hemopurifier in the scheme of things.
I would not limit the possibilities as you have described and, in fact, I would like to assume that our military WILL be on the front lines administering therapy. I cannot confirm this but it would fit in with their mission... http://online.wsj.com/articles/jonathan-d-moreno-and-stephen-n-xenakis-the-u-s-military-mission-against-ebola-1414713910
Our day will come and, as you said, it SHOULD be soon. With Doctors presenting the viral load performance stats on Friday, we should be able to turn some heads. Zuckerman, Gates, Obama and WHO knows who for example.
Military personnel are certainly trainable and procedure oriented. They are among this country's best prepared personnel for extreme and demanding circumstances. Delaying the deployment of HP would be tantamount to genocide. This is not a subject for cost benefit analysis. As philife pointed out, deploying a cure, even if it is just considered a 'potential' cure, should be done immediately to get the epidemic under control.
This is the best weapon we have to fight Ebola and it would be a crime not to use it.
Play4keeps2 - Let's get this done!
Study confirms that amount of virus in the blood upon entering treatment is key factor in survival rates.
http://news.yahoo.com/why-survive-ebola-sierra-leone-study-offers-clues-070129976.html
I think that when the IDE was approved the HP was approved for compassionate use upon a Doctor's request.
I'm surprised that the Dr in NY has not requested an HP treatment.
The virus reemergence problem described sure makes the earliest possible HP therapy critical.
I don't have a quantitative answer for you Craig, but I'm pretty sure that they can be produced very rapidly. My understanding from an investor conference I attended is that all the raw materials, etc. are readily available. Keeping up with the demand in this case may be a challenge.
Membrana is the name of the company. http://www.membrana.com/
Lets hope that credit is given where credit is due in Frankfurt. If so, I am sure that the HP will be widely deployed against the Ebola epidemic, despite any doubters.
You misread it. The patent says that it can be stored 'at least' six months.
last I heard, the shelf life is indefinite, but would be several years, if any. I do not know if that presents any issues, or if an arbitrary value is assigned for some reason.
Aethlon will grow exponentially faster than the dialysis industry did. That's one of the reasons I have been long for many years. It's plain to see that their infrastructure already exists.
Aethlon is on a team developing portable dialysis-like theraputics for DARPA. JJ probably knows what he's talking about when he says that a dialysis machine is not required for the filter. I think the filter can be much smaller than the ones that use dialysis cartridges as a platform. Conjecture, but the discovery of the mini-cartridge may have lead to the finding that the heart is a sufficient pump for the filtering process.
Production of Hemopurifiers is pretty easy with well defined standards. Last I heard Bioserv is making them. I have no idea what their production capacity is. I also believe Aethlon has a relationship with a German company that can make them. I presume that any qualified manufacturer could be used to meet needs.
Mark Zuckerberg and his wife Priscilla Chan, are donating $25 million to the U.S. Centers for Disease Control and Prevention (CDC) to fight Ebola.
Purchase order in work for Hemopurifiers?
Removing both the virus and cytokins sounds like a good idea. Getting the virus out is essential as the issue is 'cause and effect.' Virus is the cause and cytokin storm is effect.
Should be some NEWS out of Spain early next week! Things may finally start moving at the proper speed.
I'll jump in. I think it is a matter of the approach to Hemopurifier treatments, which depends on patient circumstances and the treatment duration. Dialysis patients undergo a process to create a cimino fistula port so that repeated access over a long period of time is facilitated. From my understanding of Hemopurifier treatments, this fairly complicated fistula technique which marries an artery to a vein, will not be necessary as the treatments will wrap up after a fairly short period of time needed to clear out the virus then let the medicine do the maintenance. But since the trials are being done on dialysis patients, the fistula port will probably already be there to use. There should be a white paper description of the access method(s) that are planned to be used in various circumstances (but I don't think there is one). I believe it is a fairly simple, straight forward procedure to open up a port. The potential problems arise because the port closes up after a while.
This stock has afforded me many hours of hope.